Abstract
The prevalence of asthma continues to increase and its optimal treatment remains a challenge. Here, we investigated the actions of lipoxin A4 (LXA4) and its leukocyte receptor in pulmonary inflammation using a murine model of asthma. Allergen challenge initiated airway biosynthesis of LXA4 and increased expression of its receptor. Administration of a stable analog of LXA4 blocked both airway hyper-responsiveness and pulmonary inflammation, as shown by decreased leukocytes and mediators, including interleukin-5, interleukin-13, eotaxin, prostanoids and cysteinyl leukotrienes. Moreover, transgenic expression of human LXA4 receptors in murine leukocytes led to significant inhibition of pulmonary inflammation and eicosanoid-initiated eosinophil tissue infiltration. Inhibition of airway hyper-responsiveness and allergic airway inflammation with a stable LXA4 analog highlights a unique counter-regulatory profile for the LXA4 system and its leukocyte receptor in airway responses. Moreover, our findings suggest that lipoxin and related pathways offer novel multi-pronged therapeutic approaches for human asthma.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
References
Leff, A.R. Role of leukotrienes in bronchial hyperresponsiveness and cellular responses in airways. Am. J. Resp. Crit. Care Med. 161, S125–S132 (2000).
Bousquet, J., Jeffery, P.K., Busse, W.W., Johnson, M. & Vignola, A.M. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am. J. Resp. Crit. Care Med. 161, 1720–45 (2000).
Robinson, D.S. et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. New Engl. J. Med. 326, 298–304 (1992).
Broide, D.H. et al. Cytokines in symptomatic asthma airways. J. Allergy Clin. Immunol. 89, 958–967 (1992).
Samuelsson, B. From studies of biochemical mechanisms to novel biological mediators: Prostaglandin endoperoxides, thromboxanes and leukotrienes. in Les Prix Nobel: Nobel Prizes, Presentations, Biographies Lectures. 153–174 (Almqvist & Wiksell, Stockholm, 1982).
Drazen, J.M., Israel, E. & O'Byrne, P.M. Treatment of asthma with drugs modifying the leukotriene pathway. N. Engl. J. Med. 340, 197–206 (1999).
Serhan, C.N., Haeggstrom, J.Z. & Leslie, C.C. Lipid mediator networks in cell signaling: update and impact of cytokines. FASEB J. 10, 1147–1158 (1996).
McMahon, B., Mitchell, S., Brady, H.R. & Godson, C. Lipoxins: revelations on resolution. Trends Pharmacol. Sci. 22, 391–395 (2001).
Levy, B.D., Clish, C.B., Schmidt, B., Gronert, K. & Serhan, C.N. Lipid mediator class switching during acute inflammation: Signals in resolution. Nature Immunol. 2, 612–9 (2001).
Lee, T.H. et al. Identification of lipoxin A4 and its relationship to the sulfidopeptide leukotrienes C4, D4, and E4 in the bronchoalveolar lavage fluids obtained from patients with selected pulmonary diseases. Am. Rev. Resp. Dis. 141, 1453–1458 (1990).
Badr, K.F., DeBoer, D.K., Schwartzberg, M. & Serhan, C.N. Lipoxin A4 antagonizes cellular and in vivo actions of leukotriene D4 in rat glomerular mesangial cells: Evidence for competition at a common receptor. Proc. Natl. Acad. Sci. USA 86, 3438–42 (1989).
Gronert, K., Martinsson-Niskanen, T., Ravasi, S., Chiang, N. & Serhan, C.N. Selectivity of recombinant human leukotriene D4, leukotriene B4, and lipoxin A4 receptors with aspirin-triggered 15-epi-LXA4 and regulation of vascular and inflammatory responses. Am. J. Pathol. 158, 3–9 (2001).
Takano, T. et al. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: Evidence for anti-inflammatory receptors. J. Exp. Med. 185, 1693–1704 (1997).
De Sanctis, G.T. et al. Interleukin-8 receptor modulates IgE production and B-cell expansion and trafficking in allergen-induced pulmonary inflammation. J. Clin. Invest. 103, 507–515 (1999).
De Sanctis, G.T. et al. Contribution of nitric oxide synthases 1, 2, and 3 to airway hyperresponsiveness and inflammation in a murine model of asthma. J. Exp. Med. 189, 1621–1630 (1999).
Clish, C.B. et al. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. Proc. Natl. Acad. Sci. USA 96, 8247–8252 (1999).
Holgate, S.T. The epidemic of allergy and asthma. Nature 402, B2–4 (1999).
Drazen, J.M., Silverman, E.K. & Lee, T.H. Heterogeneity of therapeutic responses in asthma. Br. Med. Bull. 56, 1054–1070 (2000).
Bryan, S.A. et al. Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 356, 2149–2153 (2000).
Leckie, M.J. et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 356, 2144–2148 (2000).
Christie, P.E., Spur, B.W. & Lee, T.H. The effects of lipoxin A4 on airway responses in asthmatic subjects. Am. Rev. Resp. Dis. 145, 1281–1284 (1992).
Dahlen, s.e. et al. Actions of lipoxin A4 and related compounds in smooth muscle preparations and on the microcirculation in vivo. Adv. Exp. Med. Biol. 229, 107–130 (1988).
Venkayya, R. et al. The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells. Am. J. Resp. Cell Mol. Biol. 26, 202–208 (2002).
Laporte, J.C. et al. Direct effects of interleukin-13 on signaling pathways for physiological responses in cultured human airway smooth muscle cells. Am. J. Resp. Crit. Care Med. 164, 141–148 (2001).
Cowburn, A.S., Holgate, S.T. & Sampson, A.P. IL-5 increases expression of 5-lipoxygenase-activating protein and translocates 5-lipoxygenase to the nucleus in human blood eosinophils. J. Immunol. 163, 456–465 (1999).
Hisada, T., Salmon, M., Nasuhara, Y. & Chung, K.F. Cysteinyl-leukotrienes partly mediate eotaxin-induced bronchial hyperresponsiveness and eosinophilia in IL-5 transgenic mice. Am. J. Resp. Crit. Care Med. 160, 571–575 (1999).
Drazen, J.M. Leukotrienes as mediators of airway obstruction. Am. J. Resp. Crit. Care Med. 158, S193–200 (1998).
Resnati, M. et al. The fibrinolytic receptor for urokinase activates the G-protein-coupled chemotactic receptor FPRL1/LXA4R. Proc. Natl. Acad. Sci. USA 99, 1359–1364 (2002).
Soyombo, O., Spur, B.W. & Lee, T.H. Effects of lipoxin A4 on chemotaxis and degranulation of human eosinophils stimulated by platelet-activating factor and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. Allergy 49, 230–234 (1994).
Bandeira-Melo, C. et al. Cutting edge: Lipoxin (LX) A4 and aspirin-triggered 15-epi-LXA4 block allergen-induced eosinophil trafficking. J. Immunol. 164, 2267–2271 (2000).
Bandeira-Melo, C. et al. Cyclooxygenase-2-derived prostaglandin E2 and lipoxin A4 accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats: Relationship with concurrent eosinophilia. J. Immunol. 164, 1029–1036 (2000).
Aliberti, J., Hieny, S., Reis e Sousa, C., Serhan, C.N. & Sher, A. Lipoxin-mediated inhibition of IL-12 production by DCs: A mechanism for regulation of microbial immunity. Nature Immunol. 3, 76–82 (2002).
Sanak, M. et al. Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics. Eur. Resp. J. 16, 44–49 (2000).
Godson, C. et al. Cutting edge: Lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J. Immunol. 164, 1663–1667 (2000).
Chiang, N. et al. Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion. J. Clin. Invest. 104, 309–316 (1999).
Wu, W. et al. Eosinophils generate brominating oxidants in allergen-induced asthma. J. Clin. Invest. 105, 1455–1463 (2000).
Acknowledgements
We thank M.H. Small for manuscript preparation, J. vom Saal for technical assistance and M. Loda of the Dana Farber/Harvard Cancer Center Pathology Core Facility. G.T.D.S. was a recipient of a Partners Investigator Nesson Award. This study was supported, in part, by National Institutes of Health grants K08-HL03788 (to B.D.L.), P50-HL56383 (to J.M.D. and B.D.L.), HL-36110 (to G.T.D.S.) and GM-38765, DK-50305 and P01-DE13499 (to C.N.S.).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Levy, B., De Sanctis, G., Devchand, P. et al. Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4. Nat Med 8, 1018–1023 (2002). https://doi.org/10.1038/nm748
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm748
This article is cited by
-
Formyl peptide receptors in the mucosal immune system
Experimental & Molecular Medicine (2020)
-
Specialized pro-resolving mediators: endogenous regulators of infection and inflammation
Nature Reviews Immunology (2016)
-
Type 2 innate lymphoid cells: at the cross-roads in allergic asthma
Seminars in Immunopathology (2016)
-
Characteristics of respiratory syncytial virus-induced bronchiolitis co-infection with Mycoplasma pneumoniae and add-on therapy with montelukast
World Journal of Pediatrics (2016)
-
Lipoxin B4 promotes the resolution of allergic inflammation in the upper and lower airways of mice
Mucosal Immunology (2015)